EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer

Aisling Forder, Rebecca Zhuang, Vanessa G P Souza iD, Liam J Brockley, Michelle E Pewarchuk, Nikita Telkar iD, Greg L Stewart, Katya Benard, Erin A Marshall iD, Patricia P Reis iD, Wan L Lam

International Journal of Molecular Sciences · 02.02.2023 · 24 (3) · 2859

DOI: 10.3390/ijms24032859 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.02.2023. Verfasst von Aisling Forder und 10 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung Neoplasms. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, the Canadian Institutes for Health Research, the BC Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer and chronic obstructive pulmonary disease (COPD) often co-occur, and individuals with COPD are at a higher risk of developing lung cancer. While the underlying mechanism for this risk is not well understood, its major contributing factors have been proposed to include genomic, immune, and microenvironment dysregulation. Here, we review the evidence and significant studies that explore the mechanisms underlying the heightened lung cancer risk in people with COPD. Genetic and epigenetic changes, as well as the aberrant expression of non-coding RNAs, predispose the lung epithelium to carcinogenesis by altering the expression of cancer- and immune-related genes. Oxidative stress generated by tobacco smoking plays a role in reducing genomic integrity, promoting epithelial-mesenchymal-transition, and generating a chronic inflammatory environment. This leads to abnormal immune responses that promote cancer development, though not all smokers develop lung cancer. Sex differences in the metabolism of tobacco smoke predispose females to developing COPD and accumulating damage from oxidative stress that poses a risk for the development of lung cancer. Dysregulation of the lung microenvironment and microbiome contributes to chronic inflammation, which is observed in COPD and known to facilitate cancer initiation in various tumor types. Further, there is a need to better characterize and identify the proportion of individuals with COPD who are at a high risk for developing lung cancer. We evaluate possible novel and individualized screening strategies, including biomarkers identified in genetic studies and exhaled breath condensate analysis. We also discuss the use of corticosteroids and statins as chemopreventive agents to prevent lung cancer. It is crucial that we optimize the current methods for the early detection and management of lung cancer and COPD in order to improve the health outcomes for a large affected population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveLung NeoplasmsHumansFemaleMaleSmokingLungInflammationComorbidityTumor Microenvironment

Stichwörter der Autor:innen

COPDepigeneticsgenomic alterationsimmune microenvironmentlung cancerlung cancer screeningmicrobiomepathogenesis

Autor:innen und Institutionen

  • British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
  • Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Molecular Oncology Laboratory, Experimental Research Unit, School of Medicine, São Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil.
  • Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
  • British Columbia Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada.

ORCID-Profile: Vanessa G P Souza, Nikita Telkar, Erin A Marshall, Patricia P Reis

Förderung

  • CIHR
  • the Canadian Institutes for Health Research
  • the BC Cancer Foundation
  • the CIHR Frederick Banting and Charles Best Canada Graduate Scholarships
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Vanier Canada Graduate Scholarship
  • The University of British Columbia

Zitieren

APA

Forder, A., Zhuang, R., Souza, V. G. P., Brockley, L. J., Pewarchuk, M. E., Telkar, N., Stewart, G. L., Benard, K., Marshall, E. A., Reis, P. P., & Lam, W. L. (2023). Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. International Journal of Molecular Sciences, 24(3), 2859. https://doi.org/10.3390/ijms24032859

Vancouver

Forder A, Zhuang R, Souza VGP, Brockley LJ, Pewarchuk ME, Telkar N, et al. Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. International Journal of Molecular Sciences. 2023;24(3):2859. doi:10.3390/ijms24032859

BibTeX
@article{Forder2023,
  author = {Forder, Aisling and Zhuang, Rebecca and Souza, Vanessa G P and Brockley, Liam J and Pewarchuk, Michelle E and Telkar, Nikita and Stewart, Greg L and Benard, Katya and Marshall, Erin A and Reis, Patricia P and Lam, Wan L},
  title = {Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2859},
  doi = {10.3390/ijms24032859}
}
Kostenlos starten →